Quinn M A
Department of Gynaecological Oncology, Royal Women's Hospital, Melbourne, Australia.
Curr Opin Obstet Gynecol. 1997 Feb;9(1):21-4.
Adenocarcinoma of the cervix may well be aetiologically, epidemiologically, and clinically different to its squamous counterpart. Overall prognosis is poorer which may relate to an increased radiation resistance or to a propensity to spread intraperitoneally. The role of neoadjuvant and adjuvant therapy is even less well defined than in squamous cancers. Future studies in carcinoma of the cervix should either be confined to one histological type, or should at least be stratified, based on whether the disease is squamous or non-squamous.
宫颈腺癌在病因学、流行病学及临床方面可能与其鳞状上皮对应物存在差异。总体预后较差，这可能与辐射抗性增加或腹膜内扩散倾向有关。新辅助治疗和辅助治疗的作用甚至比鳞状细胞癌更不明确。未来关于宫颈癌的研究要么局限于一种组织学类型，要么至少应根据疾病是鳞状还是非鳞状进行分层。
